期刊文献+

PET-CT图象融合技术对肺癌靶区定义的研究 被引量:5

Research on Target Definition of Lung Cancer by Image Fusion of PET/CT
原文传递
导出
摘要 目的:目前作为靶区定义依据,CT,MRI等影像主要反映人体解剖结构,而以PET.SPECT.MRS为代表的影像技术可以获得肿瘤内部生物学特性的影像,将对于肿瘤放射治疗靶区定义提供新的靶区范围。结果:本文针对2例典型病例,4名有经验医师分别采取目前常用CT影像和我们所得到的融合图像对肿瘤靶区定义,对比他们的定义差异。结论:利用融合技术将多种影像同时显示,对靶区的定义,尤其了解肿瘤的功能区域有重要的临床意义,可以提高靶区定义准确性,为进一步调强放射治疗以及将来的生物学靶区定义带来重要的实验和临床依据。 Objective: Now the main imaging devices used to definite the target area in radiotherapy are CT, MRI etc. that mainly provide the anatomy images. While the imaging devices such as PET, SPECT, MRS can reflect some biological information in tumor. Methods: In this study,2 typical cases were selected.According to fusion Images obtained by us and CT imaging currently used, 4 experienced doctors defined the tumors' target area and compared the differences between them. Results: The 4 doctors took a different view in the definition of the target area based on CT images, but consistent point of view according to the definition of fusion images of the tumor target area. Conclusions: By using fusion technology, a variety of images are showed at the same time,which has important clinical significance to the definition of the target area, in particular to understanding the functional areas of the tumor,providing an important experimental and clinical evidence for further radiation treatment and the definition of the biological target area.
机构地区 大庆油田总医院
出处 《现代生物医学进展》 CAS 2010年第4期734-737,共4页 Progress in Modern Biomedicine
关键词 生物靶区 PET-CT图像融合 放射治疗 Biological target area Image fusion of PET/CT Radiotherapy
  • 相关文献

参考文献4

二级参考文献15

  • 1赵春雷,高硕,陈秋松,李亚军,李大成,邢喜玲,王俊起.^(18)F-FDG PET/CT显像在非小细胞肺癌术前分期中的价值[J].中华核医学杂志,2005,25(2):78-81. 被引量:15
  • 2李万龙,于金明,范廷勇,付政,刘希斌,仲伟霞,张利民.氟脱氧葡萄糖PET-CT对非小细胞肺癌纵隔淋巴结转移的诊断价值[J].中华放射肿瘤学杂志,2005,14(3):166-169. 被引量:20
  • 3何胜利,管一晖,赵军,左传涛,董竞成.^(18)F-FDG标准摄取值对非小细胞肺癌预后的影响[J].中国肿瘤临床,2006,33(3):167-170. 被引量:9
  • 4Konishi J, Yamazaki K , TsukamotoE , et al. Mediastinal lymph . node Staging by F D G-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings. Respiration, 2003,70(5) :500 -506.
  • 5Takamochi K , Yoshida J , Murakami K , et al. Pitfalls in lymph node staging with positron emission tomography in non-small cell lung cancer patients. Lung cancer,2005,47 (2) :235 -242.
  • 6Cerfolio RJ, Ojha B,Bryant AS, et al. The accuracy of integra-ted PET-CT compared withdedicated pet alone for the staging of patients with nonsmall cell lung cancer[J]. Ann Thorac Surg,2004,78:1017-1023.
  • 7Franzius C. FDG PET: advantages for staging the mediastinum[J]. Lung Cancer,2004,45 (Supple 2): 69-74.
  • 8Antoch G, Stattaus J, Nemat AT, et al. Non-small cell lung cancer :dual-modality PET/CT inpreoperative staging[J]. Radiology, 2003, 229:526-533.
  • 9Vansteen JF. Imaging in lung cancer: position emission tomogr-aphy scan[J]. Eur Respir J,2002, 35(2):49-60.
  • 10Chapman J D, Bradley J D, Eary J F, et al. Molecular (functional) imaging for radiotherapy apphcations: an RTOG symposium[J]. Int J Radiat Oncol Biol Phys, 2003, 55(2) :294-301.

共引文献12

同被引文献53

引证文献5

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部